Merck Animal Health has introduced a groundbreaking immunotherapy for canine cancer called gilvetmab. This checkpoint inhibitor specifically designed for dogs targets the PD-1 protein, reactivating.
Phototherapy, also known as light therapy, is emerging as a promising complementary treatment for cancer in dogs. This non-invasive approach utilizes specific wavelengths of light.
Thyroid carcinoma in dogs is a serious condition that requires a comprehensive understanding and proactive management. This article combines key insights from eight detailed articles.